Zhitong Finance App News, Yuheng Pharmaceutical (002437.SZ) issued an announcement and the company signed a “Technology Transfer (Patent) Contract” with Capital Medical University. According to the “Technology Transfer Contract” agreement, the company plans to acquire the patent for “A Marker and Application of Calcium Overload Induces Neuronal Death” at a transaction price of RMB 11.15 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.